BeStock  
Stocks › Biotechnology › FDMT

4D Molecular Therapeutics FDMT

US equityMarket cap rank #3512Biotechnology
$10.23 −$0.49 (-4.57%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.23 0.00%
Open$10.36
Prev close$10.72
Day range$10.11 – $10.94
Volume691.0K
Market cap$576.76M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts7
Average target$29.00+183.5% vs. price
  • Buy 86%
  • Hold 14%
Low $20.00Now $10.23Avg $29.00High $36.00

Recent rating changes

The last 20 actions on file set price targets from $20.00 to $36.00, averaging $30.50.

DateFirmRatingTarget
12 Nov 2026 Goldman Sachs BUY $32.00
22 Oct 2026 H.C. Wainwright BUY $36.00
21 Oct 2026 BofA Securities BUY $33.00
21 Oct 2026 Morgan Stanley HOLD –
19 Oct 2026 Cantor Fitzgerald BUY $20.00
13 Oct 2026 Barclays BUY $28.00
6 Oct 2026 Chardan Capital BUY $25.00
28 Sep 2026 BofA Securities BUY $33.00
28 Sep 2026 Morgan Stanley HOLD –
21 Sep 2026 Cantor Fitzgerald BUY –
11 Sep 2026 Barclays BUY $28.00
17 Aug 2026 Morgan Stanley HOLD –
14 Aug 2026 BofA Securities BUY –
14 Aug 2026 Morgan Stanley HOLD –
14 Aug 2026 H.C. Wainwright BUY $36.00
14 Aug 2026 RBC Capital BUY $35.00
20 Jul 2026 BofA Securities BUY $29.00
20 Jul 2026 Evercore BUY $23.00
20 Jul 2026 Goldman Sachs BUY $33.00
20 Jul 2026 H.C. Wainwright BUY $36.00

Discussion

No comments yet — be the first to weigh in on FDMT.

Sign in to join the discussion.

Scroll to Top